Black Seed Oil Extract Supplement clinical trials
How each study uses Black Seed Oil Extract Supplement is sorted by a rule, right about nine times in ten. Readers can ask us to read every study one by one.Ask us to read each study
Get an email when these change. Save the Black Seed Oil Extract Supplement studies recruiting or about to start — once a week, free: studies that open, close, add sites or post results.
See an example email
Example · made-up studies
Breast cancer · Recruiting: 2 came in, 3 changed
What changed in your alerts, Oct 31 – Nov 6:
A study of drug A after surgery for early breast cancer
Came in · now Recruiting
Drug B with hormone therapy in advanced breast cancer
Changed
· Sites: 4 added, including Seoul and Busan
· Enrollment: 300 → 450 participants
Exercise during chemotherapy
Now Active, not recruiting
One email a week for all your alerts. Stop any time.
Approvals
The first approval found in each region, with its record
- United States
- Not in FDA's approval records
- European Union
- Not in EMA's list of EU-wide authorizations
From FDA's Drugs@FDA and Purple Book (through openFDA) and the European Medicines Agency, files of Sept 2026 and 27 Oct 2026. National approvals in Europe and other countries are not included. How this is worked out
How studies write it
Studies that test it under each name
Studies by the year they started
10 studies that test it; most in 2009 (3); 1 more planned to start later
| Year | Studies |
|---|---|
| 2008 | 2 |
| 2009 | 3 |
| 2019 | 1 |
| 2022 | 1 |
| 2023 | 1 |
| 2025 | 1 |
| 2026 | 1 |
By phase
A phase 1/2 study counts in both.
What it is tested for
Each study’s main condition, where its own words name it, so a study counts once.
Who runs them
Industry 7 · Other 4
NuPathe Inc. (5) · Novatek Pharmaceuticals (2) · Amr Mohamed MD (1) · Ramsar international campus (1) · M.D. Anderson Cancer Center (1) · University of Florida (1)
Often tested with
Tested in the same studies.
Studies
Open first, then newest update. How each study uses Black Seed Oil Extract Supplement is read from its arms, and is right about nine times in ten. Ask us to read each study. These are the studies that list it as an intervention; a search of ClinicalTrials.gov also finds studies that mention it only in a description, such as earlier treatment.
Testing it · 11
- A Multicenter Study Evaluating the Efficacy and Safety of Nivolumab and Ipilimumab in Combination With NP-101 Versus Placebo in Refractory Advanced and Metastatic Gastroenteropancreatic Neuroendocrine Carcinomas (GEP-NECs)Not yet recruitingPhase 2/3Novatek PharmaceuticalsNCT07935928Written as NP-101
- Phase 1 Dose Escalation and Dose Expansion Trial of NP-101 in Patients With Solid TumorsRecruitingPhase 1M.D. Anderson Cancer CenterNCT06563375Written as NP-101
- Study of the Safety, Tolerability and Efficacy of NP-101 in Treating High Risk Participants Who Are Covid-19 Positive.TerminatedPhase 2Novatek PharmaceuticalsNCT05785390Written as NP-101
- NP-101 (TQ Formula) With Nivolumab and Ipilimumab in Advanced or Metastatic Extra-pulmonary Neuroendocrine CarcinomasCompletedPhase 1Amr Mohamed MDNCT05262556Written as NP-101 (TQ Formula)
- Study of NP-101 in Patients With Unresectable Hepatocellular Carcinoma (HCC) Undergoing Y-90 TreatmentWithdrawnPhase 1University of FloridaNCT06217094Written as NP-101 (3 g)
- Black Seed Oil in Treatment of OsteoarthritisCompletedNot applicableRamsar international campusNCT06029868Written as Black seed oil capsule
- Compare PK and Bioavailability of 2 NP101 Patches With Oral Imitrex in Healthy AdultsCompletedPhase 1NuPathe Inc.NCT01381796Written as NP101
- An Open-Label Study to Evaluate the Safety of NP101 in the Treatment of Acute Migraine Over Twelve MonthsCompletedPhase 3NuPathe Inc.NCT00806546Written as NP101
- An Open-Label Study to Evaluate the Safety of NP101 in the Treatment of Acute Migraine Over 12 MonthsCompletedPhase 3NuPathe Inc.NCT00792103Written as NP101
- Phase I Open Label Single-Dose Study to Compare the Pharmacokinetics of NP101 Healthy VolunteersCompletedPhase 1NuPathe Inc.NCT00720018Written as NP101 Sumatriptan Iontophoretic Transdermal Patch
- Phase I, Open Label, Single-Dose, Four Way Crossover Study to Compare the PK of NP101 With Oral Imitrex® (50mg) in Migraine Subjects During an Acute Migraine Attack and During a Non-Migraine PeriodCompletedPhase 1NuPathe Inc.NCT00723983Written as NP101 Study Patch
What changed recently
From the registry's own updates since Oct 18, 2026.